Melanóma: vizsgálatok itt: Egyesült Államok
269 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleNilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- Where
- Easton, Iowa City, Lexington, Nashville
- Életkor
- 18 év and over
- People
- 30
- Run by
- Rina Plattner
See details and how to joinNCT04903119 - No phaseTaking peopleAssessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
- Where
- Lebanon
- Életkor
- 18 év and over
- People
- 125
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT07201376 - 1. fázisTaking peopleX-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
- Where
- Charlotte, Durham, Greenville, Washington D.C.
- Életkor
- 18 év and over
- People
- 52
- Run by
- Immunolight, LLC
See details and how to joinNCT04389281 - No phaseTaking peopleEffects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 30
- Run by
- John Kirkwood
See details and how to joinNCT06599619 - 1. fázisTaking peopleA Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- Where
- Dallas, Fairfax, Huntersville
- Életkor
- 18 év and over
- People
- 270
- Run by
- Conjupro Biotherapeutics, Inc.
See details and how to joinNCT07317505 - No phaseTaking peopleSample Collection for Ongoing Research and Product Evaluation Study
- Where
- Austin
- Életkor
- 18 év and over
- People
- 9600
- Run by
- Natera, Inc.
See details and how to joinNCT07318051 - 4. fázisTaking peopleA Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Where
- La Jolla
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00 - 1. fázisTaking peopleACTengine® IMA203 Combined With mRNA-4203
- Where
- Boston, Houston, New York, San Francisco
- Életkor
- 18 év and over
- People
- 15
- Run by
- Immatics US, Inc.
See details and how to joinNCT06946225 - 1. fázisBefejeződöttA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Canton, Columbus, Dallas, Fairfax, Houston, Los Angeles, Pittsburgh, Tamarac
- Életkor
- 18 év and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - 3. fázisTaking peopleEfficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Where
- Atlanta, Chicago, Columbus, Durham, Easton, Hershey, Houston, Iowa City, La Jolla, New Brunswick, New York, Ney York, Orange, Philadelphia, Phoenix, Richmond, Rochester, Salt Lake City, UT, Tampa
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT03567889 · EU 2023-507119-36-00 - 2. fázisTaking peopleStudy of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Where
- Chicago, Los Angeles, New Hyde Park, Tampa
- Életkor
- 18 év and over
- People
- 32
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06121180 - 1/2. fázisTaking peopleDefactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
- Where
- Iowa City, Salt Lake City
- Életkor
- 18 év and over
- People
- 33
- Run by
- University of Utah
See details and how to joinNCT06194929 - 1/2. fázisTaking peopleEvaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
- Where
- Denver, Nashville, Scottsdale
- Életkor
- 18 év and over
- People
- 36
- Run by
- Novelwise Pharmaceutical Corporation
See details and how to joinNCT07136181 - No phaseTaking peopleOpdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 20
- Run by
- John Kirkwood
See details and how to joinNCT07223411 - Korai 1. fázisTaking peopleFUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
- Where
- Charlottesville
- Életkor
- 18 év and over
- People
- 11
- Run by
- University of Virginia
See details and how to joinNCT06472661 - 2. fázisTaking peopleMirdametinib in Patients With Advanced NF1-mutant Melanoma
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 10
- Run by
- Kevin Kim, MD
See details and how to joinNCT07237100 - 2. fázisTaking peopleTime-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
- Where
- Atlanta
- Életkor
- 18 év and over
- People
- 99
- Run by
- Emory University
See details and how to joinNCT07155317 - No phaseTaking peopleBeta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
- Where
- Louisville
- Életkor
- 18 év and over
- People
- 30
- Run by
- Kelly McMasters
See details and how to joinNCT04513028 - 1/2. fázisTaking peoplePhase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
- Where
- Beverly Hills, Cleveland, Houston, Pittsburgh, Salt Lake City, Scottsdale
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- Strand Therapeutics Inc.
See details and how to joinNCT06249048 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50 000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - 1/2. fázisTaking peopleA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Where
- Boston, Dallas, Fairfax, Gilbert, Pittsburgh
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- ImmVira Pharma Co. Ltd
See details and how to joinNCT04370587 - No phaseTaking peopleStorage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment
- Where
- Nashville
- Életkor
- 18 év and over
- People
- 3000
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT01205815 - 1. fázisTaking peopleNaltrexone and Propranolol Combined With Immunotherapy
- Where
- New Brunswick
- Életkor
- 18 év and over
- People
- 12
- Run by
- Sarah Weiss
See details and how to joinNCT05968690 - No phaseTaking peopleExcision of Lymph Node Trial (EXCILYNT) (Mel69)
- Where
- Ann Arbor, Atlanta, Baltimore, Charlottesville, Durham, New York, Philadelphia
- Életkor
- 18 év and over
- People
- 66
- Run by
- Craig L Slingluff, Jr
See details and how to joinNCT05839912 - No phaseTaking peopleObservational Study of Iris Tumors
- Where
- Portland
- Életkor
- 18 év and over
- People
- 100
- Run by
- Oregon Health and Science University
See details and how to joinNCT03809585